Age-related macular degeneration (AMD) is the third leading cause worldwide blindness that causes permanent central vision impairment in older people. Over the past few years, there has been significant progress in the diagnosis and therapy of AMD. Currently available diagnostic and therapeutic strategies are clinically limited to manage AMD. The intravitreal (IVT) injection therapy has its shortcomings due to the ocular barriers and frequent administration of drugs into the vitreous humor of the eye. The safe and effective formulations will address the unmet medical needs of AMD. Various engineered nanoformulations, composed of polymers, lipids, proteins, inorganic materials, have been significantly investigated for the management of AMD over the past decade. The purpose of the review was to provide a comprehensive overview of the current state-of-the-art clinical diagnosis and treatment modalities for AMD. This review highlights the progress and future perspectives of nanodiagnostics and nanotherapeutics.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jconrel.2020.10.054 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Organic Nanoparticles in Progressing Cardiovascular Disease Treatment and Diagnosis.
Polymers (Basel)
May 2024
Department of Science and Engineering of Oxide Materials and Nanomaterials, National University of Science and Technology Politehnica Bucharest, 011061 Bucharest, Romania.
Cardiovascular diseases (CVDs), the world's most prominent cause of mortality, continue to be challenging conditions for patients, physicians, and researchers alike. CVDs comprise a wide range of illnesses affecting the heart, blood vessels, and the blood that flows through and between them. Advances in nanomedicine, a discipline focused on improving patient outcomes through revolutionary treatments, imaging agents, and ex vivo diagnostics, have created enthusiasm for overcoming limitations in CVDs' therapeutic and diagnostic landscapes.
View Article and Find Full Text PDFBioprinting extracellular vesicles as a "cell-free" regenerative medicine approach.
Extracell Vesicles Circ Nucl Acids
May 2023
The University of Queensland, Faculty of Health and Behavioural Sciences, School of Dentistry, Center for Oral-facial Regeneration, Rehabilitation and Reconstruction (COR3), Epigenetics nanodiagnostic and therapeutic group, Brisbane 4006, QLD, Australia.
Regenerative medicine involves the restoration of tissue or organ function via the regeneration of these structures. As promising regenerative medicine approaches, either extracellular vesicles (EVs) or bioprinting are emerging stars to regenerate various tissues and organs (i.e.
View Article and Find Full Text PDFNanomedicines for cardiovascular disease.
Nat Cardiovasc Res
April 2023
Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, USA.
The leading cause of death in the world, cardiovascular disease (CVD), remains a formidable condition for researchers, clinicians and patients alike. CVD comprises a broad collection of diseases spanning the heart, the vasculature and the blood that runs through and interconnects them. Limitations in CVD therapeutic and diagnostic landscapes have generated excitement for advances in nanomedicine, a field focused on improving patient outcomes through transformative therapies, imaging agents and ex vivo diagnostics.
View Article and Find Full Text PDFMulti-functionalization, a Promising Adaptation to Overcome Challenges to Clinical Translation of Nanomedicines as Nano-diagnostics and Nano-therapeutics for Breast Cancer.
Curr Pharm Des
March 2022
Department of Pharmaceutics, University of Sargodha, Sargodha, Punjab, Pakistan.
Background: Breast cancer (BC) is one of the most aggressive and prevalent types of cancer, which is associated with a high rate of mortality and colossal potential of metastasis to other body organs. Conventionally, there are three commonly employed strategies for the treatment of BC including, surgery, radiations and chemotherapy; however, these modalities are associated with several deleterious effects and a high rate of relapse.
Objective: This review was aimed to critically discuss and conceptualize existing evidences related to the pharmaceutical significance and therapeutic feasibility of multi-functionalization of nanomedicines for early diagnosis and efficient treatment of BC.
The COVID-19 pandemic is expanding worldwide. This pandemic associated with COVID-19 placed the spotlight on how bacterial (e.g.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!